Clinical Trials Browser

Unknown × Squamous Cell Carcinoma of Head and Neck × tislelizumab × Clear all

NCT06235918 2024-02-01

Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck